Australia markets closed

Assembly Biosciences, Inc. (ASMB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.36-0.09 (-0.67%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 73.25M
Enterprise value -54.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.54
Price/book (mrq)1.78
Enterprise value/revenue -7.63
Enterprise value/EBITDA 0.85

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 37.05%
S&P500 52-week change 321.08%
52-week high 320.04
52-week low 37.68
50-day moving average 313.02
200-day moving average 311.28

Share statistics

Avg vol (3-month) 326.76k
Avg vol (10-day) 313.2k
Shares outstanding 55.48M
Implied shares outstanding 65.48M
Float 83.63M
% held by insiders 133.10%
% held by institutions 113.13%
Shares short (15 Apr 2024) 430.56k
Short ratio (15 Apr 2024) 41.45
Short % of float (15 Apr 2024) 40.88%
Short % of shares outstanding (15 Apr 2024) 40.56%
Shares short (prior month 15 Mar 2024) 460.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 312 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-175.22%

Management effectiveness

Return on assets (ttm)-33.87%
Return on equity (ttm)-98.95%

Income statement

Revenue (ttm)7.16M
Revenue per share (ttm)1.57
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -64.2M
Net income avi to common (ttm)-61.23M
Diluted EPS (ttm)-13.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)130.25M
Total cash per share (mrq)23.76
Total debt (mrq)2.34M
Total debt/equity (mrq)5.70%
Current ratio (mrq)3.41
Book value per share (mrq)7.50

Cash flow statement

Operating cash flow (ttm)22.74M
Levered free cash flow (ttm)-8.2M